Elastography Imaging Market Size, Growth Forecast Report, 2026-2034
REPORT DETAILS
Elastography Imaging Market Summary
The elastography imaging market size was valued at USD 5.06 billion in 2025, exhibiting a CAGR of 6.26% during 2026–2034. The market is expanding due to the rising prevalence of chronic diseases, increasing demand for non-invasive diagnostic methods, advancements in imaging technology, and the growing need for early detection of conditions such as liver diseases and cancer, particularly breast cancer.
Market Statistics
Key Takeaways
- North America held the largest market share of 38.50% in 2025. The regional market dominance is supported by robust healthcare infrastructure and ongoing investments in research and development.
- Asia Pacific is projected to witness the fastest growth at a 7.17% CAGR. The regional market growth is driven by an aging population and improved healthcare infrastructure.
- The ultrasound segment led with a 74.0% share in 2025. This is due to its non-invasive nature and ability to assess liver diseases and tumors.
- Radiology/general imaging accounted for a 44.0% market share in 2025. This is due to its widespread use in diagnosing liver fibrosis, breast lesions, and thyroid abnormalities with real-time tissue stiffness assessment.
- The ambulatory surgery centers segment is projected to witness the fastest growth at a 7.21% CAGR. The shift towards outpatient care is projected to drive the growth of the segment.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
Industry Dynamics
- Increasing use of non-invasive diagnostic methods in liver disease management and oncology is driving demand for elastography imaging.
- Technological advancements, such as AI integration and real-time imaging, are enhancing diagnostic precision and market growth.
- The growing prevalence of chronic diseases and cancer, particularly liver diseases and breast cancer, is fueling elastography adoption.
- Strong investments in healthcare infrastructure and R&D, especially in North America and Asia Pacific, are driving market adoption.
- High equipment costs and limited healthcare access in some regions may slow market expansion, especially in low-resource settings.
AI Impact on Elastography Imaging Market
- AI integration enhances the accuracy and speed of elastography imaging, improving diagnostic precision and patient outcomes.
- Machine learning algorithms analyze tissue stiffness more effectively, identifying early-stage diseases and improving disease management.
- AI enables automated interpretation of elastography images, reducing human error and ensuring consistent, reliable results.
- The combination of AI with elastography imaging accelerates the adoption of personalized medicine, tailoring treatments to individual patients' needs.
- AI-driven advancements are making elastography imaging more accessible and cost-effective, particularly in resource-limited regions.
Source: Polaris Market Research Analysis
To Understand More About this Research: Download Sample Report
The elastography imaging market focuses on assessing tissue stiffness and elasticity. This technique is widely used in diagnosing liver diseases, cancer, and other conditions where tissue hardness serves as a critical indicator. By offering a non-invasive and 3D imaging solution, elastography has gained prominence in modern healthcare. The market is experiencing steady growth, driven by the increasing prevalence of chronic diseases and the rising demand for advanced diagnostic tools. Additionally, technological advancements in ultrasound devices and magnetic resonance imaging have enhanced the accuracy and efficiency of elastography techniques, further supporting the elastography imaging market expansion.
The growing need for early disease detection, particularly in oncology and hepatology, drives the market size. The adoption of elastography imaging is expected to increase as healthcare providers shift towards non-invasive diagnostic methods. The rising global burden of liver diseases, fueled by lifestyle-related disorders and viral infections, has further accelerated elastography imaging market demand. Additionally, the integration of artificial intelligence in medical imaging is improving diagnostic precision, making elastography a preferred choice among medical professionals.
Elastography vs Biopsy
| Aspect | Elastography Imaging | Biopsy |
| Procedure Type | Non-invasive imaging technique | Invasive sampling of tissues |
| Patient Discomfort | Low discomfort | Possibility of causing pain and/or bleeding |
| Risk Associated | Low risk | Higher risk of infection or complications |
| Time Involved | Quick process with faster results | Takes longer to perform and recover from |
| Analysis Performed | Measurement of tissue stiffness | Tissue biopsy for further analysis |
| Purpose of Technique | Screening/monitoring | Diagnosis of pathology |
Market Dynamics
Increasing Prevalence of Chronic Liver Diseases
Chronic liver diseases, including hepatitis and liver cirrhosis, have become a significant health concern worldwide. According to the Centers for Disease Control and Prevention (CDC), the death numbers for chronic liver disease and cirrhosis in 2022 reached 54,803 in the US. This upward trend underscores the urgent need for effective diagnostic tools that facilitate early detection and management of liver conditions. Elastography imaging offers a non-invasive method to assess liver stiffness, providing critical information for the diagnosis and monitoring of liver diseases. The growing incidence of liver-related ailments has consequently heightened the demand for elastography imaging systems, propelling the elastography imaging market growth.
Rising Incidence of Breast Cancer
Breast cancer remains one of the most prevalent cancers affecting women globally. The American Cancer Society reported that breast cancer is the second-leading cause of cancer-related deaths among women. For instance, the Centers for Disease Control and Prevention (CDC) reported that in 2021, approximately 272,454 cases of breast cancer were diagnosed in women in the United States. Early detection is pivotal in improving survival rates, and elastography imaging has emerged as a valuable tool in this regard. By providing detailed insights into tissue elasticity, elastography aids in distinguishing between benign and malignant breast lesions. The increasing number of breast cancer cases and breast cancer therapy has led to a greater reliance on advanced diagnostic techniques such as elastography imaging, thereby fueling the expansion of the elastography imaging market.
Technological Advancements in Elastography
Technological developments in elastography imaging have increased the effectiveness of the non-invasive diagnostic process. Shear wave elastography technologies enable healthcare professionals to obtain more precise results when assessing tissue stiffness during the diagnosis of conditions, such as liver fibrosis and tumors. Moreover, artificial intelligence-based analysis helps make radiologists' work easier by reducing their workload when interpreting images. Real-time stiffness mapping and hybrid MRI and ultrasound imaging technologies help to improve the image quality. Thus, technological developments in elastography increase the effectiveness of imaging procedures and reduce the need for invasive procedures. It broadens the scope of using elastography, which can be applied in fields such as oncology, liver diseases, cardiology, and musculoskeletal imaging.
Source: Polaris Market Research Analysis
Segment Insights
Assessment by Modality
The elastography imaging market is segmented by modality into magnetic resonance and ultrasound. Ultrasound segment dominated the market with 74.0% share in 2025. This modality's widespread adoption can be attributed to its non-invasive nature, cost-effectiveness, and versatility in assessing various medical conditions. Ultrasound elastography is extensively utilized for evaluating liver stiffness, aiding in the diagnosis and monitoring of liver diseases such as fibrosis and cirrhosis. Additionally, it plays a crucial role in oncology by assisting in the differentiation between benign and malignant tumors, particularly in breast cancer assessments. The real-time imaging capabilities and ease of integration into existing ultrasound systems further enhance its appeal among healthcare providers. The combination of these factors has solidified ultrasound elastography's position as the leading segment in the market.
Evaluation by Application
The elastography imaging market segmentation, based on application, includes cardiology, radiology/general imaging, urology, obstetrics, and others. Radiology/general imaging has emerged as the leading segment with 44.0% share in 2025 within the market. This prominence is attributed to the modality's extensive application in diagnosing and monitoring various conditions, including liver fibrosis, breast lesions, and thyroid abnormalities. The non-invasive nature of elastography, coupled with its ability to provide real-time assessment of tissue stiffness, enhances its utility in general imaging practices. Healthcare providers increasingly rely on elastography to complement traditional imaging techniques, thereby improving diagnostic accuracy and patient outcomes. The broad applicability and growing adoption of elastography in general imaging underscore its dominant position in the market.
Source: Polaris Market Research Analysis
Regional Insights
By region, the study provides the elastography imaging market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, each contributing uniquely to the market's dynamics. The market exhibits distinct trends across various regions, influenced by factors such as healthcare infrastructure, the prevalence of chronic diseases, technological advancements, and governmental initiatives.
North America recorded the largest elastography imaging market share of 38.50% in 2025. This leadership is driven by a well-established healthcare infrastructure, widespread adoption of advanced imaging technologies, and significant investments in research and development. The region benefits from the presence of numerous global market players and a proactive approach toward early disease detection and preventive healthcare. Collectively, these factors contribute to North America's dominant position in the market.
Asia Pacific is experiencing the fastest elastography imaging market growth with 7.17% CAGR. An increasing geriatric population, rising prevalence of chronic diseases, and improvements in healthcare services fuel this rapid expansion. Countries such as China and India are at the forefront, with significant investments in healthcare infrastructure and a growing emphasis on early disease detection. Additionally, the increasing medical tourism industry in the region is enhancing the adoption of advanced diagnostic technologies such as elastography imaging. These developments position Asia Pacific as the most rapidly growing market.
Source: Polaris Market Research Analysis
Key Players and Competitive Insights
The elastography imaging market features several prominent companies actively providing relevant products and solutions. Key players include Canon Medical Systems Corporation; Esaote SpA; Fujifilm Holdings Corporation; GE HealthCare; Hitachi, Ltd.; Hologic, Inc.; Koninklijke Philips N.V.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; and Samsung Medison Co., Ltd. These companies are instrumental in advancing elastography imaging technologies and maintaining a competitive presence in the market.
The competitive landscape of the market is characterized by continuous technological innovation and strategic collaborations among key industry players. Companies are investing significantly in research and development to enhance the accuracy, functionality, and real-time imaging capabilities of elastography systems. Strategic partnerships and acquisitions are common, aimed at expanding market reach and integrating complementary technologies. This dynamic environment fosters the development of advanced diagnostic tools, meeting the growing demand for non-invasive imaging solutions in various medical applications.
Canon Medical Systems Corporation, headquartered in Japan, offers a comprehensive range of medical imaging solutions, including advanced elastography imaging systems. Their product portfolio features ultrasound and magnetic resonance imaging (MRI) technologies equipped with elastography capabilities, which facilitate non-invasive assessment of tissue stiffness for applications such as liver fibrosis evaluation and oncology diagnostics. Canon's commitment to innovation and quality positions it as a significant contributor to the elastography imaging market.
GE HealthCare, based in the United States, provides a wide range of medical imaging equipment and services, with elastography imaging being a key component. Their ultrasound systems incorporate elastography features that enable clinicians to assess tissue elasticity effectively, aiding in the diagnosis of conditions such as liver disease and cancer. GE HealthCare's focus on integrating advanced technologies into its imaging solutions underscores their relevance and influence in the elastography imaging market.
List of Key Companies
- ALPINION Medical Systems Co., Ltd.
- Canon Medical Systems Corporation
- Esaote S.p.A.
- GE HealthCare
- Koninklijke Philips N.V.
- Samsung Medison Co., Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Siemens Healthineers AG
- SonoScape Medical Corp.
- VINNO Technology (Suzhou) Co., Ltd.
Industry Developments
- February 2026: Esaote Group introduced the MyLab E85 GTS and MyLab C30 GTS Edition ultrasound systems at the European Congress of Radiology (ECR). According to Esaote Group, these systems deliver contrast-enhanced, shear-wave elastography and attenuation imaging modes in a portable unit for the first time. (source: esaote.com)
- November 2025: Canon Medical Systems USA, Inc. announced receiving FDA 510(k) clearance for its Aplio i-series diagnostic ultrasound systems (Aplio i700, Aplio i800, and Aplio i900) with Software Version 9.0. The company stated that the clearance enables the introduction of advanced technologies to help clinicians achieve high-quality diagnostic images with greater efficiency. (us.medical.canon)
Future Outlook
The elastography imaging market is forecast to grow steadily in the years to come, driven by the rising incidence of chronic disorders, increasing demand for non-invasive diagnostic methods, and ongoing advances in artificial intelligence-based imaging technology. The increasing adoption of elastography in hybrid imaging systems, along with improvements in its diagnostic accuracy, is driving the growth of elastography applications. Besides this, the expansion of healthcare infrastructure and the adoption of advanced imaging technology in developing economies are other factors expected to drive the market in the coming years.
Market Segmentation
By Modality Outlook (Revenue-USD Billion, 2021–2034)
- Magnetic Resonance
- Ultrasound
By Application Outlook (Revenue-USD Billion, 2021–2034)
- Cardiology
- Radiology/General Imaging
- Urology
- Obstetrics
- Others
By End Use Outlook (Revenue-USD Billion, 2021–2034)
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Others
By Regional Outlook (Revenue-USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherlands
- Russia
- Rest f Europe
- Asia Pacific
- China
- Japan
- India
- Malaysia
- Suth Korea
- Indnesia
- Australia
- Vietnam
- Rest f Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Israel
- Suth Africa
- Rest f Middle East & Africa
- Latin America
- Mexic
- Brazil
- Argentina
- Rest f Latin America
Report Scope
| Report Attributes | Details |
| Market Size Value in 2025 | USD 5.06 Billion |
| Market Size Value in 2026 | USD 5.36 Billion |
| Revenue Forecast by 2034 | USD 8.73 Billion |
| CAGR | 6.26% from 2026 to 2034 |
| Base Year | 2025 |
| Historical Data | 2021–2024 |
| Forecast Period | 2026–2034 |
| Quantitative Units | Revenue in USD Billion and CAGR from 2026 to 2034 |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Insights |
| Segments Covered |
|
| Regional Scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, regions, and segmentation. |
Source: Polaris Market Research Analysis
How is Report Valuable for Organization?
Workflow/Innovation Strategy: The elastography imaging market has been segmented into detailed segments of modality, application, and end use. Moreover, the study provides the reader with a detailed understanding of the different segments at both the global and regional levels.
Growth/Marketing Strategy: The elastography imaging market is expanding through a combination of technological advancements, strategic partnerships, and increasing adoption in clinical diagnostics. Companies are focusing on integrating artificial intelligence and machine learning to enhance imaging accuracy and efficiency. Additionally, collaborations with healthcare institutions and research centers are driving innovation and expanding market reach. Market players are also investing in geographical expansion, particularly in emerging economies, to tap into the growing demand for advanced diagnostic tools. Furthermore, regulatory approvals and product launches continue to strengthen market presence and competitiveness.
elastography imaging market FAQ's
The elastography imaging market size was valued at USD 5.06 billion in 2025 and is projected to grow to USD 8.73 billion by 2034.
The market is projected to register a CAGR of 6.26% during the forecast period, 2026-2034.
North America held the largest market share of 38.50% in 2025.
Key players in the elastography imaging market include ALPINION Medical Systems Co., Ltd.; Canon Medical Systems Corporation; Esaote S.p.A.; GE HealthCare; Koninklijke Philips N.V.; Samsung Medison Co., Ltd.; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers AG; SonoScape Medical Corp.; VINNO Technology (Suzhou) Co., Ltd.
The radiology/general imaging segment accounted for the larger market share of 44.0% in 2025.
Elastography imaging is a medical imaging technique used to assess the stiffness or elasticity of tissues in the body.
Download Sample Report of elastography imaging market
Please fill out the form to request a customized copy of the research report.
